Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.25 Average PT from Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given a consensus recommendation of “Buy” by the six research firms that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $12.25.

A number of analysts have commented on the company. Canaccord Genuity Group decreased their price objective on Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating for the company in a report on Thursday, October 17th. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Oppenheimer cut their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Finally, Roth Mkm decreased their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently added to or reduced their stakes in the stock. Oppenheimer & Co. Inc. purchased a new stake in shares of Bioceres Crop Solutions during the 1st quarter worth approximately $139,000. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions in the first quarter valued at $212,000. Ping Capital Management Inc. purchased a new position in shares of Bioceres Crop Solutions during the 2nd quarter valued at $448,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth $472,000. Finally, Dimensional Fund Advisors LP increased its holdings in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after acquiring an additional 5,341 shares during the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

Shares of BIOX stock opened at $6.43 on Thursday. The firm has a 50 day moving average of $8.07 and a 200-day moving average of $10.02. Bioceres Crop Solutions has a 52 week low of $6.40 and a 52 week high of $14.05. The company has a market cap of $404.13 million, a price-to-earnings ratio of 160.79 and a beta of 0.49. The company has a quick ratio of 0.86, a current ratio of 1.24 and a debt-to-equity ratio of 0.35.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.92%. The business had revenue of $124.30 million during the quarter, compared to the consensus estimate of $126.75 million. During the same period last year, the business posted ($0.06) earnings per share. On average, equities analysts forecast that Bioceres Crop Solutions will post 0.31 earnings per share for the current year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.